Key points are not available for this paper at this time.
Mass spectrometry (MS) has many advantages as a quantitative detection technology for applications within drug discovery. However, current methods of liquid sample introduction to a detector are slow and limit the use of mass spectrometry for kinetic and high-throughput applications. We present the development of an acoustic mist ionization (AMI) interface capable of contactless nanoliter-scale "infusion" of up to three individual samples per second into the mass detector. Installing simple plate handling automation allowed us to reach a throughput of 100 000 samples per day on a single mass spectrometer. We applied AMI-MS to identify inhibitors of a human histone deacetylase from AstraZeneca's collection of 2 million small molecules and measured their half-maximal inhibitory concentration. The speed, sensitivity, simplicity, robustness, and consumption of nanoliter volumes of sample suggest that this technology will have a major impact across many areas of basic and applied research.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ian Sinclair
Ministry of Natural Resources and Forestry
Martin Bachman
Medicines Discovery Catapult
Daniel H. Addison
AstraZeneca (United States)
Analytical Chemistry
University of Manchester
AstraZeneca (United Kingdom)
AstraZeneca (Sweden)
Building similarity graph...
Analyzing shared references across papers
Loading...
Sinclair et al. (Tue,) studied this question.
synapsesocial.com/papers/69dd161d7a14526fc0133344 — DOI: https://doi.org/10.1021/acs.analchem.9b00142